Recent trials have demonstrated the positive effects of nasal insulin in individuals with schizophrenia, bipolar disorder, depression, smoking addiction, and improving olfaction in individuals with impairment in the sense of smell [112]. This evidence concerns the gene INS and major depressive disorder.